Evidence map›Paper›PMID 23106594›Full record

ArticleChemical research in toxicology2012

Cross-linking protein glutathionylation mediated by O2-arylated bis-diazeniumdiolate "Double JS-K".

Ryan J Holland, Anna E Maciag, Varun Kumar, Lei Shi, Joseph E Saavedra, Robert K Prud'homme, Harinath Chakrapani, Larry K Keefer

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ryan J HollandFrederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States. hollandrj@mail.nih.gov
Anna E Maciag
Varun Kumar
Lei Shi
Joseph E Saavedra
Robert K Prud'homme
Harinath Chakrapani
Larry K Keefer

Funding

Diazeniumdiolates as Broad-Spectrum Anticancer AgentsZIABC011188 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KEEFER, LARRY K · 2009 to 2015
$5.2M
Multifunctional PEG Hydrogel Nano/Microparticles for Targeted Treatment of NSCLCR01CA155061 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI SINKO, PATRICK J. · 2011 to 2015
$1.8M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIA BC011188NCI NIH HHS HHSN261200800001ENCI NIH HHS R01 CA155061NCI NIH HHS R01 CA155061-01
6 · The paper itself

Abstract

Attachment of glutathione (GSH) to cysteine residues in proteins (S-glutathionylation) is a reversible post-translational modification that can profoundly alter protein structure and function. Often serving in a protective role, for example, by temporarily saving protein thiols from irreversible oxidation and inactivation, glutathionylation can be identified and semiquantitatively assessed using anti-GSH antibodies, thought to be specific for recognition of the S-glutathionylation modification. Here, we describe an alternate mechanism of protein glutathionylation in which the sulfur atoms of the GSH and the protein's thiol group are covalently bound via a cross-linking agent, rather than through a disulfide bond. This form of thiol cross-linking has been shown to occur and has been confirmed by mass spectrometry at the solution chemistry level, as well as in experiments documenting the potent antiproliferative activity of the bis-diazeniumdiolate Double JS-K in H1703 cells in vitro and in vivo. The modification is recognized by the anti-GSH antibody as if it were authentic S-glutathionylation, requiring mass spectrometry to distinguish between them.

Indexed as

AcetylcysteineActinsAnimalsAntineoplastic AgentsAzo CompoundsCell Line, TumorDinitrofluorobenzeneFemaleGlutathioneHumansMiceMice, NudeNanoparticlesNitric OxideOxygenPiperazines1,5-difluoro-2,4-dinitrobenzeneAcetylcysteineActinsAntineoplastic AgentsAzo CompoundsDinitrofluorobenzeneGlutathioneNitric OxideO(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolateOxygenPiperazines

Identifiers

PMID23106594
PMCPMC3524378

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.